Skip to main content
Fig. 1 | International Journal of Retina and Vitreous

Fig. 1

From: Early real-world outcomes of intravitreal aflibercept 8 mg in treatment-Naïve neovascular AMD: AI-assisted fluid volume analysis

Fig. 1

Changes in retinal anatomical features. (A) Curve of changes in mean retinal thickness from baseline to 3 months follow-up. After treatment with aflibercept 8 mg mean RT significantly decreased compared to baseline. (B) Central Subfield Thickness (CST) changes overtime. (C) Fluid status at baseline and during follow-up represented as sum of liquids (intraretinal fluid, subretinal fluid and PED). ** p ≤ 0.01. Error bars represent standard deviation (SD) T0 = Baseline; T1 = 1 month; T2 = 3 months

Back to article page